Literature DB >> 2514857

Cytotoxic drugs for gastric and colorectal cancer.

D Cunningham1.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2514857      PMCID： PMC1838392          DOI： 10.1136/bmj.299.6714.1479

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.

Authors:  S A Cullinan; C G Moertel; T R Fleming; J R Rubin; J E Krook; L K Everson; H E Windschitl; D I Twito; R F Marschke; J F Foley
Journal:  JAMA       Date:  1985-04-12       Impact factor: 56.272

2.  A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A Mayo Clinic/North Central Cancer Treatment Group study.

Authors:  M J O'Connell
Journal:  Cancer       Date:  1989-03-15       Impact factor: 6.860

3.  Evaluation of the prognostic factors in gastric cancer: the effect of chemotherapy on survival.

Authors:  D Cunningham; D Hole; D J Taggart; M Soukop; D C Carter; C S McArdle
Journal:  Br J Surg       Date:  1987-08       Impact factor: 6.939

4.  Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist.

Authors:  D Cunningham; J Hawthorn; A Pople; J C Gazet; H T Ford; T Challoner; R C Coombes
Journal:  Lancet       Date:  1987-06-27       Impact factor: 79.321

5.  Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C.

Authors:  D Cunningham; M Soukop; C S McArdle; D C Carter; J F Smyth; S G Allan; S B Kaye; G Sangster; K C Calman; A W Hutcheon
Journal:  Br J Surg       Date:  1984-09       Impact factor: 6.939

6.  A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.

Authors:  J J Lokich; J D Ahlgren; J J Gullo; J A Philips; J G Fryer
Journal:  J Clin Oncol       Date:  1989-04       Impact factor: 44.544

7.  A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.

Authors:  C Erlichman; S Fine; A Wong; T Elhakim
Journal:  J Clin Oncol       Date:  1988-03       Impact factor: 44.544

8.  Cisplatin. An active drug in the treatment of disseminated gastric cancer.

Authors:  L Leichman; B McDonald; A Dindogru; M Samson; V K Vaitkevicius
Journal:  Cancer       Date:  1984-01-01       Impact factor: 6.860

9.  Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer.

Authors:  D J Wagener; S H Yap; T Wobbes; J T Burghouts; F E van Dam; H F Hillen; G J Hoogendoorn; H Scheerder; S G van der Vegt
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

10.  cis-Platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.

Authors:  A J Lacave; J Wils; E Diaz-Rubio; M Clavel; A Planting; H Bleiberg; N Duez; O Dalesio
Journal:  Eur J Cancer Clin Oncol       Date:  1985-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.